Patents matching “treatment”

US 11400072

Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy

Coherus BioSciences, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

US 11400066

Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators

INSTITUT PASTEUR DE MONTEVIDEO · Granted Aug 2, 2022 · Expires Jul 28, 2042

US 11395817

Methods and compositions for treatment of epileptic disorders

OVID THERAPEUTICS INC. · Granted Jul 26, 2022 · Expires Jul 21, 2042

US 11390667

Compositions and methods for the treatment of neuromyelitis optica

The Regents of the University of California · Granted Jul 19, 2022 · Expires Jul 14, 2042

US 11389449

Treatment of metabolic syndrome with an sGC stimulator

Cyclerion Therapeutics, Inc. · Granted Jul 19, 2022 · Expires Jul 14, 2042

US 11389433

BRD4 inhibitor treatment of IgE-mediated diseases

The Board of Regents of the University of Texas System · Granted Jul 19, 2022 · Expires Jul 14, 2042

US 11389396

Tumescent antibiotic injection for treatment of chronic skin and soft tissue infections

The Regents of the University of California · Granted Jul 19, 2022 · Expires Jul 14, 2042

US 11384055

Glycolate oxidase inhibitors for the treatment of disease

BIOMARIN PHARMACEUTICAL INC. · Granted Jul 12, 2022 · Expires Jul 7, 2042

US 11382897

Therapeutic combination for treatment of cerebellar ataxia

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 12, 2022 · Expires Jul 7, 2042

US 11376214

Compositions and methods for treatment of ocular diseases

KIORA PHARMACEUTICALS GmbH · Granted Jul 5, 2022 · Expires Jun 30, 2042

US 11376313

Cancer treatment

Propanc Pty Ltd · Granted Jul 5, 2022 · Expires Jun 30, 2042

US 11369674

Treatment method utilizing chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E2 and E1 structural proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 28, 2022 · Expires Jun 23, 2042

US 11369588

NADPH production by the 10-formyl-THF pathway, and its use in the diagnosis and treatment of disease

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jun 28, 2022 · Expires Jun 23, 2042

US 11369692

Materials and methods for treatment of Duchenne Muscular Dystrophy

Vertex Pharmaceuticals Incorporated · Granted Jun 28, 2022 · Expires Jun 23, 2042

US 11369566

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

The Regents of the University of California · Granted Jun 28, 2022 · Expires Jun 23, 2042

US 2022193051

TREATMENT OF MIGRAINE

ALLERGAN PHARMACEUTICALS INTERNTIONAL LTD [IE] · Granted Jun 23, 2022 · Expires Jun 18, 2042

US 11365413

Inhibition of poly(A) binding protein and the treatment of pain

The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

US 11364228

Gaboxadol for therapeutic treatment of 1p36 deletion syndrome

OVID THERAPEUTICS INC. · Granted Jun 21, 2022 · Expires Jun 16, 2042

US 11365246

Anti CCL24 (EOTAXIN2) antibodies for use in the treatment of hepatic diseases

CHEMOMAB LTD. · Granted Jun 21, 2022 · Expires Jun 16, 2042

US 11359246

Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors

REGENERON PHARMACEUTICALS, INC. · Granted Jun 14, 2022 · Expires Jun 9, 2042

US 11357795

Combination immunotherapies for treatment of cancer

PrimeVax Immuno-Oncology · Granted Jun 14, 2022 · Expires Jun 9, 2042

US 11357777

Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)

Cyclerion Therapeutics, Inc. · Granted Jun 14, 2022 · Expires Jun 9, 2042

US 11357832

Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase

Takeda Pharmaceutical Company Limited · Granted Jun 14, 2022 · Expires Jun 9, 2042

US 11352389

Treatment of haematological malignancies

Academisch Ziekenhuis Leiden h.o.d.n. Leids Universitair Medisch Centrum · Granted Jun 7, 2022 · Expires Jun 2, 2042